203 related articles for article (PubMed ID: 30341474)
1. Patient, tumor, and healthcare factors associated with regional variability in lung cancer survival: a Spanish high-resolution population-based study.
Rodríguez-Barranco M; Salamanca-Fernández E; Fajardo ML; Bayo E; Chang-Chan YL; Expósito J; García C; Tallón J; Minicozzi P; Sant M; Petrova D; Luque-Fernandez MA; Sánchez MJ
Clin Transl Oncol; 2019 May; 21(5):621-629. PubMed ID: 30341474
[TBL] [Abstract][Full Text] [Related]
2. Socioeconomic differences and lung cancer survival in Germany: Investigation based on population-based clinical cancer registration.
Finke I; Behrens G; Schwettmann L; Gerken M; Pritzkuleit R; Holleczek B; Brenner H; Jansen L;
Lung Cancer; 2020 Apr; 142():1-8. PubMed ID: 32044589
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology, treatment, and survival in small cell lung cancer in Spain: Data from the Thoracic Tumor Registry.
Franco F; Carcereny E; Guirado M; Ortega AL; López-Castro R; Rodríguez-Abreu D; García-Campelo R; Del Barco E; Juan O; Aparisi F; González-Larriba JL; Domine M; Trigo JM; Cobo M; Cerezo S; Calzas J; Massutí B; Bosch-Barrera J; García Coves P; Domènech M; Provencio M
PLoS One; 2021; 16(6):e0251761. PubMed ID: 34077442
[TBL] [Abstract][Full Text] [Related]
4. Lung Cancer Survival with Current Therapies and New Targeted Treatments: A Comprehensive Update from the Srinagarind Hospital-Based Cancer Registry from (2013 to 2017).
Musika W; Kamsa-Ard S; Jirapornkul C; Santong C; Phunmanee A
Asian Pac J Cancer Prev; 2021 Aug; 22(8):2501-2507. PubMed ID: 34452564
[TBL] [Abstract][Full Text] [Related]
5. Cancer survival in adult patients in Spain. Results from nine population-based cancer registries.
Chirlaque MD; Salmerón D; Galceran J; Ameijide A; Mateos A; Torrella A; Jiménez R; Larrañaga N; Marcos-Gragera R; Ardanaz E; Sant M; Minicozzi P; Navarro C; Sánchez MJ;
Clin Transl Oncol; 2018 Feb; 20(2):201-211. PubMed ID: 28718071
[TBL] [Abstract][Full Text] [Related]
6. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
7. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
8. Treatment and survival disparities in lung cancer: the effect of social environment and place of residence.
Johnson AM; Hines RB; Johnson JA; Bayakly AR
Lung Cancer; 2014 Mar; 83(3):401-7. PubMed ID: 24491311
[TBL] [Abstract][Full Text] [Related]
9. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
[TBL] [Abstract][Full Text] [Related]
10. The Care and Outcomes of Older Persons with Lung Cancer in England and the United States, 2008-2012.
Andreano A; Peake MD; Janes SM; Valsecchi MG; Pritchard-Jones K; Hoag JR; Gross CP
J Thorac Oncol; 2018 Jul; 13(7):904-914. PubMed ID: 29727739
[TBL] [Abstract][Full Text] [Related]
11. Trends in lung cancer incidence by histologic subtype in the south of Spain, 1985-2012: a population-based study.
Linares I; Molina-Portillo E; Expósito J; Baeyens JA; Suárez C; Sánchez MJ
Clin Transl Oncol; 2016 May; 18(5):489-96. PubMed ID: 26329296
[TBL] [Abstract][Full Text] [Related]
12. The role of comorbidity in the management and prognosis in nonsmall cell lung cancer: a population-based study.
Nilsson J; Berglund A; Bergström S; Bergqvist M; Lambe M
Acta Oncol; 2017 Jul; 56(7):949-956. PubMed ID: 28486004
[TBL] [Abstract][Full Text] [Related]
13. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
Guldbrandt LM
Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
[TBL] [Abstract][Full Text] [Related]
14. Barriers to Combined-Modality Therapy for Limited-Stage Small Cell Lung Cancer.
Pezzi TA; Schwartz DL; Mohamed ASR; Welsh JW; Komaki RU; Hahn SM; Sepesi B; Pezzi CM; Fuller CD; Chun SG
JAMA Oncol; 2018 Aug; 4(8):e174504. PubMed ID: 29302695
[TBL] [Abstract][Full Text] [Related]
15. Factors Associated With Treatment of Clinical Stage I Non-Small-cell Lung Cancer: A Population-based Analysis.
Berry MF; Canchola AJ; Gensheimer MF; Gomez SL; Cheng I
Clin Lung Cancer; 2018 Sep; 19(5):e745-e758. PubMed ID: 30149883
[TBL] [Abstract][Full Text] [Related]
16. Is low survival for cancer in Eastern Europe due principally to late stage at diagnosis?
Minicozzi P; Walsh PM; Sánchez MJ; Trama A; Innos K; Marcos-Gragera R; Dimitrova N; Botta L; Johannesen TB; Rossi S; Sant M;
Eur J Cancer; 2018 Apr; 93():127-137. PubMed ID: 29518726
[TBL] [Abstract][Full Text] [Related]
17. NSCLC patient "migration" for treatment: A retrospective analysis of patient characteristics, travel patterns, and survival differences.
Pham D; Bhandari S; Pinkston C; Oechsli M; Kloecker G
Curr Probl Cancer; 2020 Aug; 44(4):100528. PubMed ID: 31771790
[TBL] [Abstract][Full Text] [Related]
18. Trends in net survival lung cancer in six European Latin countries: results from the SUDCAN population-based study.
Bordoni A; Uhry Z; Antunes L;
Eur J Cancer Prev; 2017 Jan; 26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study():S70-S76. PubMed ID: 28005608
[TBL] [Abstract][Full Text] [Related]
19. Lung cancer survival in Spain and prognostic factors: a prospective, multiregional study.
de Cos JS; Miravet L; Abal J; Núñez A; Muñoz FJ; García L; Castañar AM; Montero MA; Hernández J; Alonso MA
Lung Cancer; 2008 Feb; 59(2):246-54. PubMed ID: 17889402
[TBL] [Abstract][Full Text] [Related]
20. Treatment and survival of patients with non-small cell lung cancer Stage IIIA diagnosed in 1989-1994: a study in the region of the Comprehensive Cancer Centre East, The Netherlands.
van Dijck JA; Festen J; de Kleijn EM; Kramer GW; Tjan-Heijnen VC; Verbeek AL;
Lung Cancer; 2001 Oct; 34(1):19-27. PubMed ID: 11557109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
